Lymphoma
The UCSF clinical trials page for lymphoma lists a phase‑I hyperpolarized carbon‑13 pyruvate MRI study to evaluate detecting CNS lymphoma.
The UCSF Lymphoma Clinical Trials page lists multiple active studies, including a phase I investigation of hyperpolarized ^13C‑pyruvate MRI for detecting primary central nervous system lymphoma.
If the claim is true, the study could introduce a non–invasive imaging biomarker to diagnose and monitor primary CNS lymphoma earlier and more safely than current methods.
Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.
Related signals
- Diffuse Large B‑Cell Lymphoma – Global Clinical Trial Landscape (2024)
- Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
- Mantle‑Cell Lymphoma (MCL)
- Inhibition of autoantigen‑induced B‑cell receptor (BCR) internalization as a therapeutic strategy in diffuse large B cell lymphoma (DLBCL)
- Successful treatment of primary refractory DLBCL/HGBL - MYC/BCL2 transformed from FL using glofitamab: a case report